[1]王芳,资捷*,刘泽滨,等.RIG-I配体poly(dAT:dAT)诱导Bewo细胞抑制乙型肝炎病毒复制的研究[J].中国计划生育和妇产科,2017,(11):58-62.
　WANG Fang,ZI Jie*,LIU Ze-bin,et al.Study of RIG-I ligand poly(dAT:dAT)-induced inhibition hepatitis B virus replication in Bewo cells[J].Chinese Journal of Family Planning & Gynecotokology,2017,(11):58-62.
点击复制

RIG-I配体poly(dAT:dAT)诱导Bewo细胞抑制乙型肝炎病毒复制的研究
分享到：

《中国计划生育和妇产科》[ISSN:1674-4020/CN:51-1708/R]

卷:
期数:
2017年11期
页码:
58-62
栏目:
论著与临床
出版日期:
2017-11-25

文章信息/Info

Title:
Study of RIG-I ligand poly(dAT:dAT)-induced inhibition hepatitis B virus replication in Bewo cells
作者:
王芳; 资捷*; 刘泽滨; 方小龙; 邱丽影; 朱国胜
深圳市福田区妇幼保健院
Author(s):
WANG Fang; ZI Jie*; LIU Ze-bin; FANG Xiao-long; QIU Li-ying; ZHU Guo-sheng
Shenzhen Futian Women and Children Health Care Hospital,Shenzhen Guangdong 518026,P.R.China
关键词:
维甲酸诱导基因-I; 线粒体抗病毒信号蛋白; 乙型肝炎病毒; 病毒复制; 信号传导
Keywords:
retinoic acid-inducible-I; mitochondrial antiviral signaling protein;  hepatitis B virus; virus replication; signal transduction
分类号:
R 5126+2
摘要:
目的探讨维甲酸诱导基因-I（retinoic acid inducible gene I,RIG-I）配体poly(dAT:dAT)抑制人滋养层细胞Bewo中乙型肝炎病毒(hepatitis B virus，HBV)复制的作用及机制，为防治HBV宫内感染提供依据。方法首先将2μg 13倍HBV全基因重组质粒pcDNA31(+)-HBV13转染Bewo细胞12 h后，以RIG-I配体poly(dAT:dAT)处理24 h。然后，以poly(dAT:dAT)处理Bewo细胞，观察干扰素-β（interferon-β，IFN-β）表达的动力学。采用微粒子酶免疫分析法和荧光定量聚合酶链反应法分别检测HBsAg、HBeAg和HBV DNA水平，并以酶联免疫吸附测定和逆转录PCR分别检测IFN-β水平，RIG-I、线粒体抗病毒信号蛋白（mitochondrial antiviral signaling protein，MAVS）、干扰调节因子3（interferon regulatory factor 3，IRF 3）和核因子-κB （NF-κB）的表达。结果poly(dAT:dAT)可显著诱导Bewo细胞产生IFN-β(P＜005)，呈时间和剂量依赖性。与对照组比较，poly(dAT:dAT)处理组HBsAg、HBeAg和HBV DNA水平显著下降(P＜005)，可显著抑制Bewo细胞中HBV复制。且poly(dAT:dAT)可诱导HBV重组质粒转染的Bewo细胞表达RIG-I、MAVS、IRF 3和NF-κB mRNA。结论通过RIG-I/MAVS信号途径诱导Bewo细胞产生IFN-β，RIG-I配体poly(dAT:dAT)可显著抑制HBV复制。
Abstract:
ObjectiveTo explore the effect and mechanism of retinoic acid inducible I(RIG-I) ligand poly(dAT:dAT)-mediated inhibition hepatitis B virus(HBV) replication in Bewo cells. MethodsFirstly，2μg 13-fold HBV recombinant vector pcDNA31(+)-HBV13 were transfected into Bewo cells.After 12 h the cells were treated with RIG-I ligand poly(dAT:dAT) for 24 h. Then Bewo cells were exposed to poly(dAT:dAT) to observe the kinetics of interferon-β(IFN-β) expression in Bewo cells. To detect HBsAg, HBeAg and HBV DNA level in the culture supernatant by microparticle enzyme immunoassay (MEIA) and fluorescence quantitative polymerase chain reaction (PCR). And to assay IFN-β level and RIG-I，MAVS，IRF3，NF-κB mRAN expression by ELISA and RT-PCR，respectively. ResultsCompared with control, poly(dAT:dAT) could striking induce the production of IFN-β in Bewo cells(P＜005)，in time- and dose-dependent manners. And it could significantly suppresse HBV replication in Bewo cells (P＜005).Compared with control group，the mRNA levels of RIG-I，MAVS，IRF3 and NF-κB were significantly induced by poly(dAT:dAT) in the Bewo cells transfected with this recombinant vector. ConclusionRIG-I ligand poly(dAT:dAT) could significantly suppress HBV replication by inducing IFN-β production in Bewo cells mainly via the RIG-I/MAVS signal pathway.

参考文献/References:

［1］GUO Yan, LIU Jianqiong, MENG Liping, et al.Survey of HBsAg-positive pregnant women and their infants regarding measures to prevent maternal-infantile transmission［J］.BMC Infect Dis, 2010, 10 (1): 26-31. ［2］Ramos HJ, Gale M.RIG-I like receptors and their signaling crosstalk in the regulation of antiviral immunity［J］.Curr Opin Virol, 2011, 1(3): 167-176. ［3］Koshiba T.Mitochondrial-mediated antiviral immunity［J］. Biochim Biophys Acta, 2013, 1833(1): 225-232. ［4］LI Xiao-dong, Chiu YH, Ismail AS, et al.Mitochondrial antiviral signaling protein (MAVS) monitors commensal bacteria and induces an immune response that prevents experimental colitis［J］. Proc Natl Acad Sci USA, 2011, 108(42): 17390-17395. ［5］资捷，王前，郑磊，等.1.3倍乙型肝炎病毒全基因真核表达载体的构建及其在Bewo细胞中的表达 ［J］.热带医学杂志，2010，10 （2）：126-129. ［6］DENG Min, ZHOU Xin, GAO Sheng, et al.The effects of telbivudine in late pregnancy to prevent intrauterine transmission of the hepatitis B virus: a systematic review and meta-analysis［J］. Virol J, 2012, 9(1): 185. ［7］Abrahams VM, Schaefer TM, Fahey JV, et al.Expression and secretion of antiviral factors by trophoblast cells following stimulation by the TLR-3 agonist, Poly(I : C)［J］.Hum Reprod, 2006, 21(9): 2432-2439. ［8］Ramos HJ, Gale M.RIG-I like receptors and their signaling crosstalk in the regulation of antiviral immunity［J］.Curr Opin Virol, 2011, 1(3): 167-176. ［9］Boga JA, De Oa M, Melon S, et al.MAVS: a new weapon in the fight against viral infections ［J］.Recent Pat Endocr Metab Immune Drug Discov, 2013, 7(2): 115-119. ［10］CHEN Xiaojuan, QIAN Yuanyu, YAN Fei, et al.5'-triphosphate-siRNA activates RIG-I-dependent type I interferon production and enhances inhibition of hepatitis B virus replication in HepG2.2.15 cells ［J］.Eur J Pharmacol, 2013, 721(1/3): 86-95. ［11］Sato S, LI Kai, KAMEYAMA Takeshi, et al.The RNA sensor RIG-I dually functions as an innate sensor and direct antiviral factor for hepatitis B virus［J］.Immunity, 2015, 42(1): 123-132.

备注/Memo

备注/Memo:
深圳市科创委基金资助项目（编号：JCYJ20150402154553256）
更新日期/Last Update: 2017-11-25